- Home
- LIFW vs LIPO Comparison
LIFW vs LIPO Comparison
Compare LIFW & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIFW
- LIPO
- Stock Information
- Founded
- LIFW 2014
- LIPO 2005
- Country
- LIFW United States
- LIPO United States
- Employees
- LIFW N/A
- LIPO N/A
- Industry
- LIFW Computer Software: Prepackaged Software
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- LIFW Technology
- LIPO Health Care
- Exchange
- LIFW Nasdaq
- LIPO Nasdaq
- Market Cap
- LIFW 2.8M
- LIPO 3.2M
- IPO Year
- LIFW N/A
- LIPO 2022
- Fundamental
- Price
- LIFW $0.07
- LIPO $2.43
- Analyst Decision
- LIFW
- LIPO Strong Buy
- Analyst Count
- LIFW 0
- LIPO 1
- Target Price
- LIFW N/A
- LIPO $2.00
- AVG Volume (30 Days)
- LIFW 16.3M
- LIPO 132.1K
- Earning Date
- LIFW 11-14-2024
- LIPO 11-26-2024
- Dividend Yield
- LIFW N/A
- LIPO N/A
- EPS Growth
- LIFW N/A
- LIPO N/A
- EPS
- LIFW N/A
- LIPO N/A
- Revenue
- LIFW $10,734,000.00
- LIPO $483,533.00
- Revenue This Year
- LIFW $293,208.70
- LIPO N/A
- Revenue Next Year
- LIFW N/A
- LIPO N/A
- P/E Ratio
- LIFW N/A
- LIPO N/A
- Revenue Growth
- LIFW 217.86
- LIPO 0.78
- 52 Week Low
- LIFW $0.06
- LIPO $2.21
- 52 Week High
- LIFW $7.10
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- LIFW 27.68
- LIPO 36.24
- Support Level
- LIFW $0.08
- LIPO $2.24
- Resistance Level
- LIFW $0.20
- LIPO $3.48
- Average True Range (ATR)
- LIFW 0.03
- LIPO 0.37
- MACD
- LIFW -0.00
- LIPO -0.05
- Stochastic Oscillator
- LIFW 8.49
- LIPO 17.09
About LIFW MSP Recovery Inc.
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.